Document Detail


Protective effects of beta-blockers in cerebrovascular disease.
MedLine Citation:
PMID:  17296916     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Because activated sympathetic tone is associated with poorer outcome after stroke, we investigated whether beta-blocker treatment was associated with lesser stroke severity and improved outcome. METHOD: We prospectively studied 111 patients with stroke. Stroke severity on presentation gauged by Canadian Neurologic Scale (CanNS) and medication use verified from medical records. Power spectral analysis of heart rate variability estimated cardiac sympathovagal tone. Coagulation and inflammatory activity were assessed. RESULTS: On multiple linear regression, beta-blocker use was the sole independent predictor of less severe stroke on presentation (95% CI: 0.12 to 1.86: p = 0.03). When CanNS was dichotomized, multiple logistic regression revealed that beta-blocker use (odds ratio [OR] 3.70, 95% CI: 1.24 to 11.01, p = 0.02) and female gender (OR 2.96, 95% CI: 1.14 to 7.69, p = 0.03) were independent predictors of CanNS score >8.5. There was no difference in blood pressure and blood glucose between these two groups. Beta-blocker treatment was associated with lower sympathovagal tone (p = 0.001), thrombin (p = 0.009), hemoglobin A(1)C levels (p = 0.02), and erythrocyte sedimentation rate (p = 0.003). CONCLUSION: Beta-blocker use is associated with less severe stroke on presentation and may be cerebroprotective due to a sympatholytic effect associated with decreased thrombin, inflammation, and hemoglobin A(1)C.
Authors:
Somchai Laowattana; Stephen M Oppenheimer
Related Documents :
6822026 - Hemodynamic effects of intravenous labetalol in essential hypertension.
7246746 - Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hyp...
21563986 - A novel tool for the prediction of tablet sticking during high speed compaction.
2896556 - Epinephrine and left ventricular function in humans: effects of beta-1 vs nonselective ...
1279516 - Pressure-clamp: a method for rapid step perturbation of mechanosensitive channels.
3396676 - Respiratory muscle force and ventilatory function in adolescents.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Neurology     Volume:  68     ISSN:  1526-632X     ISO Abbreviation:  Neurology     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-02-13     Completed Date:  2007-03-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  509-14     Citation Subset:  AIM; IM    
Affiliation:
Baylor College of Medicine, Houston, TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Aged
Blood Sedimentation
Female
Hemoglobin A, Glycosylated / metabolism
Humans
Linear Models
Male
Middle Aged
Neuroprotective Agents / therapeutic use*
Prognosis
Severity of Illness Index
Sex Factors
Stroke / blood,  drug therapy*,  physiopathology
Sympathetic Nervous System / physiopathology
Thrombin / metabolism
Treatment Outcome
Vagus Nerve / physiopathology
Grant Support
ID/Acronym/Agency:
NS R01-33770/NS/NINDS NIH HHS; RR-00052/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Hemoglobin A, Glycosylated; 0/Neuroprotective Agents; EC 3.4.21.5/Thrombin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
Next Document:  Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.